Aligos Therapeutics Inc. (ALGS)
23.97
0.02 (0.10%)
At close: Jan 30, 2025, 11:56 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 15.53M | 13.91M | 4.36M | n/a | n/a | n/a |
| Cost of Revenue | 3.07M | 3.67M | 104.15M | 3.33M | 2.30M | 1.29M |
| Gross Profit | 12.46M | 10.23M | -99.79M | -3.33M | -2.30M | -1.29M |
| Operating Income | -88.13M | -97.58M | -128.32M | -97.83M | -54.04M | -13.66M |
| Interest Income | 1.24M | 1.64M | 132.00K | 1.26M | 1.56M | 163.00K |
| Pretax Income | -86.88M | -95.94M | -128.19M | -108.38M | -52.18M | -13.93M |
| Net Income | -87.68M | -96.05M | -128.33M | -108.54M | -52.26M | -13.93M |
| Selling & General & Admin | 30.62M | 26.41M | 28.53M | 17.94M | 10.01M | 3.21M |
| Research & Development | 73.04M | 85.08M | 104.15M | 79.89M | 44.04M | 10.46M |
| Other Expenses | n/a | n/a | n/a | -10.55M | 302.00K | -435.00K |
| Operating Expenses | 103.66M | 111.49M | 132.68M | 97.83M | 54.04M | 13.66M |
| Interest Expense | n/a | 1.64M | 132.00K | 10.55M | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 102.96M | 111.49M | 132.68M | 97.83M | 54.04M | 13.66M |
| Income Tax | 795.00K | 106.00K | 143.00K | 161.00K | 85.00K | -272.00K |
| Shares Outstanding (Basic) | 24.87M | 42.70M | 39.86M | 34.18M | 21.93M | 21.17M |
| Shares Outstanding (Diluted) | 24.87M | 42.70M | 39.86M | 34.18M | 21.93M | 21.17M |
| EPS (Basic) | -3.52 | -2.25 | -3.22 | -3.18 | -2.38 | -0.66 |
| EPS (Diluted) | -3.52 | -2.25 | -3.22 | -3.18 | -2.38 | -0.66 |
| EBITDA | -85.06M | -93.91M | -124.54M | -105.06M | -49.88M | -12.37M |
| Depreciation & Amortization | 3.07M | 3.67M | 3.78M | 3.33M | 2.30M | 1.29M |